Biomarkers for detecting and monitoring breast cancer
AssigneeSun Jet Biotechnology Inc.
InventorYeou-Guang Tsay
Life of this patent
Estimating the term…
Abstract
Disclosed is a method for diagnosing a patient's breast cancer (BC) health state, or change in BC health state, or for diagnosing risk of BC or the presence of BC in a patient, comprising detecting, in a plasma sample from said patient, one or more biomarker values that corresponds to thrombospondin-1 (THBS1) or a THBS1-containing complex structure by performing a capillary electrophoresis under non-reducing conditions, and assigning the patient as having or not having BC, or having or not having a change in BC health state, or having or not having a risk of BC based on said biomarker values.
Claims10
A method for diagnosing a patient's breast cancer (BC) health state, or change in BC health state, or for diagnosing risk of BC or the presence of BC in a patient, comprising:
- detecting, in a plasma sample from said patient, one or more biomarker values that correspond to thrombospondin-1 (THBS1) or a THBS1-containing complex structure by performing a capillary electrophoresis under non-reducing conditions;
- and
- assigning the patient as having or not having BC, or having or not having a change in BC health state, or having or not having a risk of BC based on said biomarker values.
A kit for performing a method for diagnosing a patient's breast cancer (BC) health state, or change in BC health state, or for diagnosing risk of BC or the presence of BC in a patient, comprising a capture reagent for thrombospondin-1 (THBS1) or a THBS1-containing complex structure, and instructions for performing the method.
Dependencies are inferred from the claim text.